Chargement en cours...
Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis
As biologic-based medication options for ulcerative colitis expand, our understanding of their optimal use in clinical practice is advancing as well. The appropriate use of combination therapy with immunomodulators can reduce the immunogenicity of biologic agents and raise serum drug levels of the b...
Enregistré dans:
Publié dans: | Therap Adv Gastroenterol |
---|---|
Auteurs principaux: | , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
SAGE Publications
2016
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913335/ https://ncbi.nlm.nih.gov/pubmed/27366223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16643242 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|